What is the aim of the FINESSE trial?
The aim of the FINESSE trial was to compare the outcomes of Facilitated Percutaneous Coronary Intervention (PCI) with those of Primary PCI in patients with ST-segment elevation myocardial infarction (STEMI). The FINESSE trial was designed to assess whether facilitated PCI could reduce the amount of time it takes to perform the procedure, as well as improve clinical outcomes compared to primary PCI. This was done by comparing the door-to-balloon time and mortality rates between both types of PCI. The FINESSE trial was conducted between 2004 and 2007. The results of the trial showed that the door-to-balloon time was significantly reduced in the facilitated PCI group, but there was no significant difference in mortality rates between the two groups. 